About The Study: This cross-sectional study of patients with de novo metastatic breast cancer (dnMBC) found racial and ethnic disparities in disease presentation and inequities in timely treatment for dnMBC across subtypes, emphasizing the need for tailored interventions to improve care delivery and outcomes. De novo metastatic breast cancer, defined as the presence of distant metastases at initial diagnosis, accounts for only 5.4% to 10.0% of new cases but disproportionately contributes to breast cancer mortality in the U.S.

Researchers have developed a new methodology that uses artificial intelligence (AI) tools to identify and count target viruses more efficiently than previous techniques. The new approach can be used in applications such as pharmaceutical biomanufacturing.

New research shows there's no need to 'go hard' at the gym to become fitter and stronger.

Over the years, scientific research has led to the development of several pharmacological therapies for this disease. Now, a study coordinated by the University of Trento (Italy) marks a turning point, as it identified a gene therapy for individuals with cystic fibrosis caused by a specific mutation and for whom there was no treatment available until now. They are about 10% of all those with the disease. The results open up further prospects because they could lead to a definitive cure for patients with cystic fibrosis who are currently dependent on drugs.

A new ultra-efficient microchip developed at MIT enables resource-constrained wireless biomedical devices to implement post-quantum encryption protocols that can defend against cyberattacks from powerful quantum computers.